ExonHit Launches Mouse Genome SpliceArray(TM) for use in Human Disease Modeling Studies.
PARIS, November 28 /PRNewswire-FirstCall/ -- ExonHit Therapeutics S.A. (Alternext: ALEHT), a drug and diagnostic discovery company, announces today the availability of its new SpliceArray(TM) for use in studying mouse models of human disease. These SpliceArray(TM) products help our clients accelerate and refine their therapeutic target discovery and validation efforts....

The Backup files; A look back at the week in business.
Byline: Lisa Eckelbecker COLUMN: THE BACKUP FILES Drink up! Hey, college kids! Tired of beer pong? Feeling like it's so yesterday to hoist a cold one every time Republican vice presidential candidate Sarah Palin says "maverick?" Us too. That's why we've made up...

Use of infliximab for the treatment of pemphigus vulgaris.
This study is currently recruiting patients. Verified and sponsored by National Institute of Allergy and Infectious Diseases (NIAID). Pemphigus vulgaris (PV) is a rare skin disorder that causes blistering of the skin and mucous membranes. Infliximab is a synthetic antibody used to treat certain types of immune system disorders,...

Atypical fatigue.
Case Study: Mrs. S is a 63-year-old retired teacher who returns to the office for breast cancer follow-up. She was diagnosed with intraductal carcinoma, and her treatment included a modified radial mastectomy followed by four cycles of doxorubicin and cyclophosphamide. Her tumor was estrogen receptor-positive, progesterone receptor-positive, and human...

Green time: unplug and unwind outdoors.
Before Reading * Ask students how much time they typically spend outdoors in a given week. Discuss * What are the health benefits of spending time outdoors? (reduction in weight; development of muscles and bones; drop in risk for various diseases; increased absorption...

The new medical technologies and the organizations of medical science and treatment.
Despite remarkable scientific and technological achievements during the 20th century, the 21st century has already witnessed additional new and profound changes in all areas of medical science and research, including innovations and discoveries in biology, cellular biology, genomics and proteomics, pharmaceuticals, medical devices, and information technology. Some have noted...

Abbott Laboratories opens new $450 million Puerto Rico plant.
Byline: Lisa Eckelbecker Abbott Laboratories yesterday opened a $450 million drug manufacturing plant in Puerto Rico that will take over most of the production of Humira, a blockbuster drug for immune disorders that has been produced in Worcester. The 330,000-square-foot Abbott Biotechnology Ltd. plant in...

MedImmune In-Licenses Novel Inflammatory Disease Target.
GAITHERSBURG, Md., Dec. 28 /PRNewswire-FirstCall/ -- MedImmune, Inc. announced today that it intends to develop a monoclonal antibody (MAb) targeting pathways within the CD28 receptor family for treatment of certain inflammatory diseases under a recently signed license agreement with Japan Tobacco, Inc. (JT). MedImmune's initial efforts will focus on...

The Sick Building Syndrome.
4534 Sick Building Syndrome and the Problem of Uncertainty: Environmental Politics, Technoscience, and the Problem of Uncertainty, by Michelle Murphy. Duke University Press, 905 W., Box 90660, Durham NC27708-0660, 2006. 253 pp., ill., index. Price: $US 74.95 cloth, $US 21.95pbk. Michelle Murphy is presently an...

Cera Products Tackle Food-Linked Diarrheal Illness Outbreaks.
Also effective for diarrhea linked to C. difficile and antibiotic use COLUMBIA, Md., Nov. 2 /PRNewswire/ -- An increase in widespread outbreaks of diarrheal illness and some deaths linked to contaminated food supplies in the U.S., including spinach and carrot juice from California and, most recently, fresh...